Floatz logo

UMBELLATINE

Female

Tianjin Anding HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Female cohort.

Asset / SponsorPhaseRating
FULVESTRANT
Istituti Clinici Scientifici Maugeri SpA
D
Palbociclib
Istituti Clinici Scientifici Maugeri SpA
D
99mTc-DARPinG3
Tomsk National Research Medical Center of the Russian Academy of Sciences
D
Metformin
Tianjin Anding Hospital
N/AD
Letrozole
Istituti Clinici Scientifici Maugeri SpA
D

Same molecule, other indications

UMBELLATINE is also rated in:

inherited lipid metabolism disorderDormant
BBB
Indicative ·
72 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →